1 September 2020 - 31 August 2021
Parent institution: Boehringer Ingelheim International GmbH
Subject/journal group: All
The table to the right includes counts of all research outputs for Boehringer Ingelheim Pharmaceuticals, Inc. published between 1 September 2020 - 31 August 2021 which are tracked by the Nature Index.
Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.
Note: Articles may be assigned to more than one subject area.
Outputs by subject (Share)
|Journal of the American Chemical Society||1||0.55|
Top articles by Altmetric score in current window
Rapid evolution and host immunity drive the rise and fall of carbapenem resistance during an acute Pseudomonas aeruginosa infection
Selective SIRPα blockade reverses tumor T cell exclusion and overcomes cancer immunotherapy resistance
Journal of Clinical Investigation
KIM-1 mediates fatty acid uptake by renal tubular cells to promote progressive diabetic kidney disease.
Journal of the American Chemical Society
Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.